SLCH yields 2000000.00% · ABBV yields 3.06%● Live data
📍 SLCH pulled ahead of the other in Year 1
Combined, SLCH + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SLCH + ABBV for your $10,000?
Spotlight Capital Holdings, Inc., through its subsidiaries, provides maintenance, repair, and overhaul products and services for aircraft in the general aviation sector in Florida. It offers various services that include federal aviation administration (FAA) certified repair station, major and minor airframe repairs, annual inspections, computerized aircraft weight and balance, aircraft modifications and STC kit installations, routine maintenance/insurance and accident repairs, composite airframe repairs, and pre-purchase inspections/log book analysis. The company also provides oxygen service/nitrogen service, service parts, janitrol/southwind heater service/AD compliance inspections, dye/fluorescent penetrant inspection service, aircraft exterior and interior detailing services, ACES dynamic propeller balancing service, avionics installations and repairs, minor paint repairs and detailing, instrument panel upgrades and component installs, engine scanners and monitor installation, and EGT/CHT calibration, as well as engine maintenance, repair, and overhaul, including custom installations and refurbishment. In addition, it offers charter air services for both passengers and cargo from South Florida to the Bahamas with leased aircraft. The company was formerly known as AvStar Aviation Group, Inc. and changed its name to Spotlight Capital Holdings, Inc. in November 2014. The company is headquartered in Houston, Texas. Spotlight Capital Holdings, Inc. was founded in 1987 and is based in Houston, Texas.
Full SLCH Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.